Christer Ahlberg about the present and the future of Cinclus Pharma
Christer Ahlberg, CEO of Cinclus Pharma since June 2021, shares his thoughts about the company's current position and future vision.
Read more![Cinclus Pharma News Christer Ahlberg, CEO about the present and the future of Cinclus Pharma](/media/541detg1/cinclus-news-2540x1200-christer-ahlberg-ceo.jpg?width=620&height=300&v=1d82a2e6179e3f0)
Check out the latest news from Cinclus Pharma
Christer Ahlberg, CEO of Cinclus Pharma since June 2021, shares his thoughts about the company's current position and future vision.
Read moreDuring Life Science Sweden's conference "Pharma Outsourcing", Kjell Andersson, CSO at Cinclus Pharma, was interviewed about our drug candidate linaprazan glurate, which is an acid secretion inhibitor, a so-called P-CAB.
Read moreThe story of Cinclus Pharma started when a chemist, a pharmacologist, a gastroenterologist, and three experts in finance and business development came together to address the unmet medical need for reflux disease treatment.
Read more